欧洲胶原蛋白市场，按产品类型（明胶、水解胶原蛋白、天然胶原蛋白、胶原蛋白肽、其他）、类型（I 型、II 型、III 型、IV 型）、形式（粉末、液体）、来源（牛、家禽、猪、海洋、其他）、产品类别（转基因、非转基因）、功能（质地、稳定剂、乳化剂、发现、其他）、应用（食品、饮料、营养保健品和膳食补充剂、化妆品和个人护理、动物饲料、实验室测试、其他）国家（德国、英国、意大利、法国、西班牙、瑞士、荷兰、比利时、俄罗斯、丹麦、瑞典、波兰、土耳其和欧洲其他地区）行业趋势和预测到 2028 年。
市场分析和洞察：欧洲胶原蛋白市场
预计胶原蛋白市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 4.9% 的复合年增长率增长，预计到 2028 年将达到 11.5466 亿美元。消费者对饮料的需求不断增加是市场增长的一个驱动因素。
胶原蛋白是一种纤维成分，提取自各种动物（如猪、猫、鱼等）的骨骼、肌腱、韧带以及皮肤。胶原蛋白用于制造各种药物，有助于治疗心脏病以及缓解关节疼痛。胶原蛋白还用于化妆品中，可以滋润皮肤、减少皱纹和强化皮肤。它在食品、饮料、膳食补充剂和其他许多领域都有广泛的应用。
已发现的主要制约因素是动物源性过敏风险增加，这限制了胶原蛋白市场的增长。此外，食品添加剂使用方面的严格规定和监管也是制造商在生产创新胶原蛋白产品时面临的问题。因此，制造商正专注于创新加工技术，以生产有助于应对全球胶原蛋白市场限制的创新产品。推动胶原蛋白市场增长的因素包括个人护理和制药行业对精油的需求增加、食品补充剂行业对胶原蛋白的需求增加、消费者对健康生活的天然产品的接受度增加以及对胶原蛋白健康益处的认识增加，而高生产成本可能会抑制胶原蛋白市场的增长。
本胶原蛋白市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
欧洲胶原蛋白市场范围和市场规模
胶原蛋白市场根据产品类型、种类、形式、来源、产品类别、功能和应用进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据产品类型，市场细分为明胶、水解胶原蛋白、天然胶原蛋白、胶原蛋白肽等。2021 年，明胶领域预计将占据市场主导地位，因为它是最基本的胶原蛋白产品类型，广泛应用于食品和制药行业。
- 根据类型，市场分为 I 型、II 型、III 型和 IV 型。2021 年，I 型细分市场预计将占据市场主导地位，因为它价格实惠，并且来自食品工业的副产品，成本低廉。
- 根据形式，市场分为粉末和液体。2021 年，粉末部分占据市场主导地位，因为粉末胶原蛋白有助于保持食物的味道。
- 根据来源，市场分为牛、家禽、猪、海产品和其他。牛部分进一步细分为黄牛、水牛、牦牛和其他。2021 年，猪部分预计将占据市场主导地位，因为从猪皮和猪骨中提取的产品价格低廉。然而，猪胶原蛋白在市场上受到限制，因为该产品不被视为清真食品，可能因宗教信仰而不能食用。
- 根据产品类别，市场分为转基因和非转基因。2021 年，非转基因产品预计将占据市场主导地位，因为该产品源于消费者对转基因食品有害影响的担忧。
- 根据功能，市场细分为质地、稳定剂、乳化剂、发现和其他。 2021 年，稳定剂领域预计将占据市场主导地位，因为胶原蛋白作为稳定剂与水胶体相容，质地光滑，不促进水分离，使其成为各种食品和饮料产品中的理想稳定剂。
- 根据应用，市场细分为食品、饮料、营养品和膳食补充剂、化妆品和个人护理、动物饲料、实验室测试等。2021 年，食品领域预计将占据主导地位，因为该产品广泛用于果酱、果冻、汤、酱汁和烘焙产品。
欧洲胶原蛋白市场：国家层面分析
胶原蛋白市场根据产品类型、种类、形式、来源、产品类别、功能和应用进行细分。
欧洲胶原蛋白市场报告涵盖的国家包括德国、英国、法国、土耳其、俄罗斯、意大利、西班牙、瑞士、荷兰、比利时、丹麦、瑞典、波兰和欧洲其他国家。
由于胶原蛋白在化妆品、膳食补充剂等各种应用中的接受度越来越高，德国有望在市场上占据主导地位。此外，德国的食品工业发展迅速，大量使用胶原蛋白作为食品成分之一，因此德国在市场上占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
胶原蛋白需求不断增长
欧洲胶原蛋白市场还为您提供每个国家行业增长的详细市场分析，包括销售额、零部件销售额、胶原蛋白技术发展的影响以及监管环境的变化及其对欧洲胶原蛋白市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和欧洲胶原蛋白市场份额分析
欧洲胶原蛋白市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对欧洲胶原蛋白市场的关注有关。
胶原蛋白市场的一些主要参与者包括 Ashland、DSM、Collagen Solutions Plc、Rousselot、GELITA AG、Advanced BioMatrix Inc.、COBIOSA、ConnOils LLC、ET-Chem、Ewald-Gelatine GmbH、Gelnex、Holista Colltech、ITALGELATINE SpA、Jellagen、Juncà Gelatines SL、KENNEY & ROSS LIMITED MARINE GELATIN、Lapi Gelatine Spa、Nippi. Inc.、PB Leiner、WEISHARDT、Vital Proteins LLC、Norland Products、Amicogen, Inc.、Titan Biotech、SMPNutra.com 等。
欧洲胶原蛋白市场比较分散，主要参与者采用合作、认可、协议等各种策略来扩大其在胶原蛋白市场的影响力。
例如，
- 2021 年 7 月，Geltor 推出了一种名为 PrimaColl 的生物活性胶原蛋白，该胶原蛋白不含任何动物成分，纯度高。该植物基产品适用于食品和饮料行业
- 2020 年 6 月，雀巢宣布同意收购 Vital Proteins 的多数股权，因为该产品的需求不断增长。该公司的决定是由于该产品在营养领域的使用日益增加
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE COLLAGEN MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION METHOD COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 VENDOR SHARE ANALYSIS
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 IMPORT EXPORT ANALYSIS
4.2 EUROPE COLLAGEN MARKET: LIST OF SUBSTITUTES
4.3 EUROPE COLLAGEN MARKET: MARKETING STRATEGIES
4.3.1 LAUNCHING NEW INNOVATIVE PRODUCTS
4.3.2 PROMOTION OF THEIR PRODUCTS BY EMPHASIZING DIFFERENT APPLICATIONS
4.3.3 A VAST NETWORK OF DISTRIBUTION
4.3.4 LAUNCHING CLEAN, SUSTAINABLE AND ORGANIC PRODUCTS FOR HEALTH-CONSCIOUS CONSUMERS
4.3.5 POPULARITY OF PLANT-BASED MEAT ALTERNATIVE
4.4 EUROPE COLLAGEN MARKET: PATENT ANALYSIS
4.4.1 DBMR ANALYSIS
4.4.2 COUNTRY-LEVEL ANALYSIS
4.4.3 YEARWISE ANALYSIS
4.4.4 PATENT ANALYSIS BY COMPANY
4.5 EUROPE COLLAGEN MARKET: PRODUCTION & CONSUMPTION PATTERN
4.6 EUROPE COLLAGEN MARKET: RAW MATERIAL PRICING ANALYSIS
5 REGULATORY FRAMEWORK
6 IMPACT OF COVID-19 IMPACT ON THE EUROPE COLLAGEN MARKET
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE EUROPE COLLAGEN MARKET
6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE EUROPE COLLAGEN MARKET
6.3 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.4 IMPACT ON PRICE
6.5 IMPACT ON DEMAND
6.6 IMPACT ON SUPPLY CHAIN
6.7 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING USAGE OF COLLAGEN PRODUCTS IN THE COSMETIC INDUSTRY
7.1.2 SUBSTANTIAL DEMAND FOR THE COLLAGEN PRODUCTS AS FOOD STABILIZER
7.1.3 RISING COLLAGEN AS INGREDIENTS IN SUPPLEMENTS FOR SPORTS ATHLETES
7.1.4 GROWTH IN THE USE OF COLLAGEN PROTEINS IN THE MEDICAL AND PHARMACEUTICAL INDUSTRY
7.1.5 GROWTH OF FISHING INDUSTRY TO USE FISH AS A RAW MATERIAL FOR GELATIN PRODUCTION
7.2 RESTRAINTS
7.2.1 INCREASING STRINGENT REGULATIONS REGARDING THE USE OF FOOD ADDITIVES
7.2.2 REGULATIONS OVER THE IMPORTS OF RAW MATERIAL FOR THE PRODUCTION OF GELATIN AND COLLAGEN PRODUCTS IN EUROPEAN UNION
7.2.3 RISK OF DISEASE TRANSFER FROM ANIMAL SOURCES
7.2.4 REGULATIONS UPON THE SLAUGHTERING OF FARM AND POULTRY ANIMALS
7.3 OPPORTUNITIES
7.3.1 RISING COLLAGEN APPLICATION AS BIOMATERIALS IN THE LABORATORIES
7.3.2 RECENT TECHNOLOGICAL ADVANCEMENTS, INCLUDING THE FORMATION OF COLLAGEN-BASED PELLET AS GENE DELIVERY CARRIER
7.3.3 RISING COLLAGEN AS INGREDIENTS IN SUPPLEMENTS FOR SPORTS ATHLETES
7.4 CHALLENGES
7.4.1 LACK OF ADVANCED PROCESSING TECHNOLOGIES FOR COLLAGEN EXTRACTION
7.4.2 HIGH PROCESSING COSTS IN THE COLLAGEN INDUSTRY
7.4.3 COMPLICATED GMO CERTIFICATION PROCESS FOR COLLAGEN PRODUCTS LABELLING
8 EUROPE COLLAGEN MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 GELATIN
8.3 HYDROLYZED COLLAGEN
8.4 NATIVE COLLAGEN
8.5 COLLAGEN PEPTIDE
8.6 OTHERS
9 EUROPE COLLAGEN MARKET, BY TYPE
9.1 OVERVIEW
9.2 TYPE I
9.3 TYPE II
9.4 TYPE III
9.5 TYPE IV
10 EUROPE COLLAGEN MARKET, BY FORM
10.1 OVERVIEW
10.2 POWDER
10.3 LIQUID
11 EUROPE COLLAGEN MARKET, BY SOURCE
11.1 OVERVIEW
11.2 BOVINE
11.3 POULTRY
11.4 PORCINE
11.5 MARINE
11.6 OTHERS
12 EUROPE COLLAGEN MARKET, BY PRODUCT CATEGORY
12.1 OVERVIEW
12.2 GMO
12.3 NON-GMO
13 EUROPE COLLAGEN MARKET, BY FUNCTION
13.1 OVERVIEW
13.2 TEXTURE
13.3 STABILIZER
13.4 EMULSIFIER
13.5 FINDING
13.6 OTHERS
14 EUROPE COLLAGEN MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 FOOD PRODUCTS
14.3 BEVERAGES
14.4 NUTRACEUTICALS AND DIETARY SUPPLEMENTS
14.5 COSMETICS AND PERSONAL CARE
14.6 ANIMAL FEED
14.7 LABORATORY TESTS
14.8 OTHERS
15 EUROPE COLLAGEN MARKET, BY REGION
15.1 EUROPE
16 EUROPE COLLAGEN MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 GELITA AG
18.1.1 COMPANY SNAPSHOT
18.1.2 PRODUCT PORTFOLIO
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 RECENT DEVELOPMENTS
18.2 ROUSSELOT
18.2.1 COMPANY SNAPSHOT
18.2.2 PRODUCT PORTFOLIO
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 RECENT DEVELOPMENTS
18.3 DSM
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 ASHLAND
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 WEISHARDT
18.5.1 COMPANY SNAPSHOT
18.5.2 PRODUCT PORTFOLIO
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 RECENT DEVELOPMENTS
18.6 AMICOGEN
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 ITALGELATINE S.P.A.
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ADVANCED BIOMATRIX, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 COBIOSA
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 COLLAGEN SOLUTIONS PLC
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENTS
18.11 CONNOILS LLC
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 ET-CHEM
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 EWALD-GELATINE GMBH
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 GELNEX
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 HOLISTA COLLTECH
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 JELLAGEN
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 JUNCÀ GELATINES SL
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 KENNEY & ROSS LIMITED MARINE GELATIN
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 LAPI GELATINE S.P.A.
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 NIPPI COLLAGEN NA INC.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 NORLAND PRODUCTS INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 PB LEINER (A PART OF TESSENDERLO GROUP)
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 SMPNUTRA
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 TITAN BIOTECH
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENT
18.25 VITAL PROTEINS LLC
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 IMPORT DATA OF PRODUCT: 3503 GELATIN …HS CODE: 3503 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 3503 GELATIN …HS CODE: 3503 (USD THOUSAND)
TABLE 3 IMPORT DATA OF PRODUCT: 3504 PEPTONES AND THEIR DERIVATIVES; OTHER PROTEIN SUBSTANCES AND THEIR DERIVATIVES, N.E.S.; HIDE…HS CODE: 3504 (USD THOUSAND)
TABLE 4 EXPORT DATA OF 3504 PEPTONES AND THEIR DERIVATIVES; OTHER PROTEIN SUBSTANCES AND THEIR DERIVATIVES, N.E.S.; HIDE…HS CODE: 3504 (USD THOUSAND)
TABLE 5 COLLAGEN RAW MATERIAL PRICE ANALYSIS IN 2020 (PER KGS)
TABLE 6 PERCENTAGE OF COLLAGEN YIELD FROM DIFFERENT SOURCES
TABLE 7 FOUR COMMON TYPES OF COLLAGEN AND THEIR RESPECTIVE LOCATION
图片列表
FIGURE 1 EUROPE COLLAGEN MARKET: SEGMENTATION
FIGURE 2 EUROPE COLLAGEN MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE COLLAGEN MARKET: DROC ANALYSIS
FIGURE 4 EUROPE COLLAGEN MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE COLLAGEN MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE COLLAGEN MARKET: THE PRODUCT TYPE LIFELINE CURVE
FIGURE 7 EUROPE COLLAGEN MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 10 EUROPE COLLAGEN MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 12 EUROPE COLLAGEN MARKET: SEGMENTATION
FIGURE 13 ASIA PACIFIC IS EXPECTED TO DOMINATE THE EUROPE COLLAGEN MARKET, AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 GROWTH IN THE USE OF COLLAGEN PROTEINS IN THE MEDICAL AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE EUROPE COLLAGEN MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 COLLAGEN DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE COLLAGEN MARKET IN 2021 & 2028
FIGURE 16 PATENT REGISTERED FOR COLLAGEN BY COUNTRY (2016 - 2021)
FIGURE 17 PATENT REGISTERED YEAR (2016 - 2021)
FIGURE 18 CONCENTRATION OF EACH AMINO ACID IN HYDROLYSED COLLAGEN (IN %)
FIGURE 19 EUROPE COLLAGEN MARKET BY PRODUCTION (USD MILLION)
FIGURE 20 CONSUMPTION OF COLLAGEN BY REGION (USD MILLION)
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE COLLAGEN MARKET
FIGURE 22 ESTIMATED PRODUCTION OF COSMETICS IN THAILAND (2017-2020) (USD BILLION)
FIGURE 23 PERCENTAGE OF SPORTS NUTRITION NEW PRODUCT LAUNCHES TRACKED WITH COLLAGEN EUROPELY (2012-2016)
FIGURE 24 EUROPE COLLAGEN MARKET: BY PRODUCT TYPE, 2020
FIGURE 25 EUROPE COLLAGEN MARKET: BY TYPE, 2020
FIGURE 26 EUROPE COLLAGEN MARKET: BY FORM, 2020
FIGURE 27 EUROPE COLLAGEN MARKET: BY SOURCE, 2020
FIGURE 28 EUROPE COLLAGEN MARKET: BY PRODUCT CATEGORY, 2020
FIGURE 29 EUROPE COLLAGEN MARKET: BY FUNCTION, 2020
FIGURE 30 EUROPE COLLAGEN MARKET: BY APPLICATION, 2020
FIGURE 31 EUROPE COLLAGEN MARKET: SNAPSHOT, 2020
FIGURE 32 EUROPE COLLAGEN MARKET: BY COUNTRY, 2020
FIGURE 33 EUROPE COLLAGEN MARKET: BY COUNTRY, 2020
FIGURE 34 EUROPE COLLAGEN MARKET: BY COUNTRY, 2020
FIGURE 35 EUROPE COLLAGEN MARKET: BY PRODUCT TYPE, 2020
FIGURE 36 EUROPE COLLAGEN MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
